<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02122848</url>
  </required_header>
  <id_info>
    <org_study_id>hsl 2013-48</org_study_id>
    <nct_id>NCT02122848</nct_id>
  </id_info>
  <brief_title>Exercise Tolerance in Patients With Decompensated Heart Failure</brief_title>
  <official_title>Effects of Bilevel Positive Airway Pressure on Exercise Tolerance in Patients With Decompensated Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Sirio-Libanes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Sirio-Libanes</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of airway bilevel positive pressure on
      the improvement of exercise tolerance in patients with decompensated heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure causes limitation of functional capacity and worsening of exercise tolerance.
      The airway pressure as adjuvant of cardiac rehabilitation has demonstrated improvement of
      functional capacity, decrease of respiratory work, increase of oxygenation and pulmonary
      compliance. Objective: to evaluate the effectiveness of the bilevel positive airway pressure
      (BILEVEL) in the increase of exercise tolerance in patients with decompensated heart failure.
      Method: this is a cross-over randomized clinical trial, with individuals who will undergo a
      submaximal progressive exercise test of the lower limbs with a cycle-ergometer using
      continuous positive airway pressure (CPAP) and BILEVEL in a random order. Patients will also
      be evaluated using a health related quality of life questionnaire, pulmonary function test,
      inspiratory muscle and peripheral muscle strength tests. Hypothesis: The increase in exercise
      tolerance might be greater during the use of BILEVEL.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endurance time of exercise in cycle ergometer.</measure>
    <time_frame>4 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>4 days</time_frame>
    <description>Dyspnea will be evaluated by means of the modified Borg scale before and after exercise.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Bilevel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention will be performed using BiLevel ventilation mode with EPAP=10 cmH2O and a IPAP which manages 6-8ml/kg tidal volume.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiLevel</intervention_name>
    <description>The intervention will be performed using BiLevel ventilation mode with EPAP=10 cmH2O and a IPAP which manages 6-8ml/kg tidal volume.</description>
    <arm_group_label>Bilevel</arm_group_label>
    <other_name>BiPAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects who has heart failure functional class II or III of New York heart
             association

          -  over 18 years

          -  non-smokers

          -  without cognitive or motor deficit

          -  without vasoactive drugs or low doses

          -  without recent acute myocardial myocardium (&lt;1 year)

          -  without recent cardiac surgery (&lt;1 year)

          -  without pulmonary disease

          -  without bronchodilators

        Exclusion Criteria:

          -  unstable angina

          -  atrial fibrillation and atrioventricular block third degree

          -  frequent vomiting

          -  respiratory instability while collecting data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wellington Yamaguti</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Sirio-Libanes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospitalsiriolibanes</name>
      <address>
        <city>SÃ£o Paulo</city>
        <zip>01308-050</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2014</study_first_submitted>
  <study_first_submitted_qc>April 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2014</study_first_posted>
  <last_update_submitted>April 20, 2015</last_update_submitted>
  <last_update_submitted_qc>April 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Sirio-Libanes</investigator_affiliation>
    <investigator_full_name>Wellington Yamaguti</investigator_full_name>
    <investigator_title>Wellington Pereira dos Santos Yamaguti</investigator_title>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Exercise tolerance</keyword>
  <keyword>Noninvasive ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

